A novel recombinant hirudin, RGD-hirudin, inhibits the activity of thrombin and the aggregation of platelets. Here, we successfully expressed 15 N, 13 C-labeled RGD-hirudin in Pichia pastoris in a fermenter. The protein was subsequently purified to yield sufficient quantities for structural and functional studies. The purified protein was characterized by HPLC and MALDI-TOF mass spectroscopy. Analysis revealed that the protein was pure and uniformly labeled with 15 N and 13 C. A bioassay showed that the anti-thrombin activity and the anti-platelet aggregation ability of the labeled protein were the same as those of unlabeled RGD-hirudin. Multidimensional heteronuclear NMR spectroscopy has been used to determine almost complete backbone 15 N, 13 C and 1 H resonance assignments of the r-RGD-Hirudin. The 15 N-1 H HSQC spectrum of uniformly 15 N, 13 C-labeled RGD-hirudin allowed successful assignment of the signals. Examples of the quality of the data are provided for the 15 Nl H correlation spectrum, and by selected planes of the CBCA(CO)NH, CBCANH, and HNCO experiments. These results provide a basis for further studies on the structure-function relationship of RGD-hirudin with thrombin and platelets.
Introduction
Hirudin, an antithrombotic substance produced by the salivary glands of the medicinal leech (Hirudo medicinalis) [1, 2] , is the most potent and specific thrombin inhibitor currently known. It blocks the thrombin-mediated conversion of fibrinogen to fibrin in clot formation, and, unlike heparin, it is a direct thrombin inhibitor (DTI) [3] , which is not inactivated by platelet factor 4 (PF4) [4, 5] .
Today, two preparations of recombinant hirudin are marketed: lepirudin (Refludan, Pharmion, UK and Berlex Laboratories, USA) and desirudin (Revasc, Novartis) [6] . Although there are minor differences in the amino-terminal composition of the two, the mechanism of interaction between hirudin and thrombin is identical: the carboxyl-terminal tail of hirudin binds to the substrate-binding site on thrombin and the globular aminoterminal domain then interacts with the active site of thrombin [7] .
RGD-hirudin is a novel bi-functional molecule that contains the Arg-Gly-Asp (RGD) adhesion site recognition sequence. The abilities of this protein to inhibit thrombin and the aggregation of platelets were confirmed in our previous study [8] . More recent studies have focused on the structure-function relationship of RGD-hirudin. NMR was used to study its solution structure [9] . Purified 15 N-labeled RGD-hirudin was prepared in our lab [10] .
However, the interaction sites and precise mechanism between RGD-hirudin and its substrate are still unclear.
In this study, we describe the successful expression of 15 N, 13 Clabeled RGD-hirudin in yeast, Pichia pastoris (GS115). In total, 600 mg of 15 N, 13 C-labeled RGD-hirudin was generated through this, and we obtained a sufficient amount of purified and uniformly labeled RGD-hirudin for solution structure studies by NMR. Two-and three-dimensional double and triple resonance NMR techniques have been successfully applied to obtain most backbone 1 H 15 N, 13 C and 13 CO assignments of r-RGDHirudin(1-66).
Materials and Methods
Pichia pastoris cells carrying the RGD-hirudin gene (Mut + ) were obtained from our lab. Briefly, the RGD-hirudin gene was synthesized in the Key Laboratory of Molecular Medicine at Fudan University. The cDNA encoding RGD-hirudin was cloned into the plasmid pPIC9K. The resulting expression vector was transformed into Pichia pastoris GS115. Vector integration into the Pichia pastoris chromosome was confirmed by PCR analyses [8] .
Yeast nitrogen base with (or without) ammonium sulfate or amino acids was obtained from Sigma Aldrich. Isotope-enriched (98%) 15 N ammonium sulfate, isotope-enriched (99%) 13 C-glycerol and isotope-enriched (99%) 13 C-methanol were obtained from Cambridge Isotope Lab. Blood plasma was from the Shanghai Blood Center. D 2 O and DCl for NMR experiments were from Sichuan Torch Chemistry Engineering Cooperation. Other reagents were of analytical purity. Sephacryl S-100 HR, Sephadex-G50, and Q-Sepharose-FF were purchased from GE.
Protein Expression
The production of the unlabeled RGD-hirudin was carried out in a fermenter (NBS Bioflow 3000) [11] . The production phase lasted 20 h at 30uC with a gradual increase in the methanol feeding rate, from 0.8 to 11.2 mL/L?h, allowing the culture to adapt to methanol consumption. After 6 h, the methanol feed rate was maintained at 11.2 mL/L?h for an additional 14 h.
The production of the 15 N, 13 C-labeled RGD-hirudin was carried out in the same fermenter vessel. BMD medium contained 100 mmol/L potassium phosphate (pH 6.0), 0.34% yeast nitrogen base without ammonium sulfate or amino acids, 1% 15 For the expression of uniformly 15 N, 13 C-labeled RGD-hirudin, a single colony was picked and grown in 5 mL of BMD medium at 30uC overnight. This culture was diluted (1:40) into 195 mL BMD medium and grown at 30uC until OD 600 reached 4.0. The culture was transferred into 1.5 L medium in the fermenter and grown in batch mode for 20 h. A sharp increase in dissolved oxygen (DO) occurred when the OD 600 reached 60, triggering a program for limited glycerol feed. 13 C-glycerol (50%, v/v) was added from 4 mL/L?h to 40 mL/L?h for 3 h. In total, 120 mL 13 C-glycerol (50%, v/v) was used until the OD 600 reached 125; 50 g ( 15 NH 4 ) 2 SO 4 was dissolved in 120 mL 13 C-glycerol. The methanol-fed phase began once all the glycerol had been consumed. During 13 C-methanol feeding, 22 g ( 15 NH 4 ) 2 SO 4 dissolved in 50 mL H 2 O was added over 20 h. The fermenter was programmed to maintain the DO at 35% saturation and to maintain the pH at 5 by automatic addition of 4.0 mol/L KOH and 7.4 mol/L NaOH [14] .
Protein Purification
The culture was centrifuged and the supernatant was ultrafiltered, followed by gel filtration and anion exchange chromatography. The concentrated supernatant was loaded onto a Sephacryl-S100 column (9.5 cm 6100 cm), pre-equilibrated with 20 mMol/L phosphate buffer (PB, pH 7.4). A volume of 1000 mL collected sample, which was eluted from the gel filtration, was loaded onto a Q-Sepharose FF column (2.6 cm 620 cm), also preequilibrated with 20 mmol/L PB (pH 7.4). It was washed with 20 mmol/L PB (pH 7.4), followed by a single linear gradient of 0-1.0 mol/L NaCl-PB buffer. RGD-hirudin was eluted at 0.25 mol/ L NaCl-PB. The sample that contained anti-thrombin activity was collected and desalted with Sephadex-G50 (1.6 cm 620 cm). The loading sample volume was 5 mL each time. Protein concentration was measured by the Bradford assay. The desalted sample was lyophilized and stored in 280uC.
Protein Identification
Protein samples (both fermenter supernatant and purified protein) were analyzed by 15% SDS-PAGE.
The anti-thrombin activity of RGD-hirudin was tested by the Titration Testing Method, according to Markwardt [15] . Briefly, 200 mL of fresh plasma was added to a 1.5-mL tube; a 5-mL sample of RGD-hirudin was added to the plasma and mixed by vortexing. Thrombin (5 mL of 100 NIH units) was added to the above mixture and allowed to stand for 1 min at 37uC: if the plasma did not clot, the RGD-hirudin had 100 anti-thrombin units. Thus, consumption of each 1 NIH unit of thrombin is equivalent to 1 anti-thrombin unit.
A classic turbidity assay was used to measure the anti-platelet aggregation activity of RGD-hirudin [8] .
HPLC-MS (Waters) was used to assess the purity and labeling efficiency of RGD-hirudin. Homogeneity of the purified protein was further confirmed using a Bruker Autoflex II. Both 15 N, 13 Clabeled and unlabeled RGD-hirudin were examined.
NMR Spectroscopy
Samples for NMR contained 2 mmol/L I5 N/ l3 C-labeled RGDhirudin, which was dissolved in 90% H 2 O/10% D 2 O, and the pH was adjusted with 1 mol/L DCl to 4.2-7.4. All NMR spectra were recorded on a Bruker DMX600 spectrometer equipped with a pulsed field gradient at 25uC. The following 3D spectra were recorded: CBCA(CO)NH [16] , CBCANH [17] , and HNCO [18] . The chemical shift of 15 N was referenced indirectly [19] . The 2D 15 N-1 H HSQC spectra were recorded using the sensitivityenhanced protocol with gradient echo-antiecho coherence selection. A time-proportional phase increment was used to discriminate between the positive and negative ( 15 N) frequencies. Trim pulses were used in INEPT transfers [20] [21] [22] . NMR data processing and analysis were carried out using a Bruker XWIN-NMR and the Sparky software.
Results
Production of Unlabeled and 15 
N, 13 C-labeled RGDhirudin
After 20 h of methanol induction, the anti-thrombin activity of the expressed product in the culture was up to 12,500 ATU/mL, as determined by fibrinogen solidification assay. SDS-PAGE showed that the expression level of unlabeled RGD-hirudin was as high as 85% of the culture (Fig. 1a) . The expression level of 15 N, 13 C-labeled RGD-hirudin was the same as that of the unlabeled protein (Fig. 1b) .
Purification and Characterization of Unlabeled and 15 N, 13 C-labeled RGD-hirudin
The protein was purified by gel filtration and anion exchange chromatography, as described in the Materials and Methods. Finally, 300 mg unlabeled RGD-hirudin (Fig. 1c, lane 1) and 250 mg 15 N, 13 C-labeled RGD-hirudin were obtained (Fig. 1c , lane 2; Table 1 ).
The anti-thrombin specific activity of the purified 15 N, 13 Clabeled RGD-hirudin was more than 10,000 ATU/mg, the same as that of unlabeled RGD-hirudin (Table 2) .
Anti-platelet aggregation activities of the proteins were determined by a classic turbidity assay. The results showed there was no the significant difference between unlabeled RGD-hirudin and 15 N, 13 C-labeled RGD-hirudin (Fig. 2) .
HPLC analyses revealed that the purity of the unlabeled RGDhirudin (data not shown) and labeled RGD-hirudin (Fig. 3a) was up to 98%.
A mass spectrum of the unlabeled sample in Figure 3b showed its molecular weight was 7021 Da; the molecular weight of 15 N, 13 C-labeled RGD-hirudin was 7387 Da (Fig. 3c) . The isotope labeling ratio calculated from MS was more than 98%, providing a basis for further studies of the structure-function relationship of RGD-hirudin by NMR and other methods. 15 N, 13 C-labeled RGD-hirudin was recorded and is shown in Figure 4a . The 15 N-1 H HSQC analysis of a labeled protein displays one peak for each nitrogen-bound hydrogen atom (one peak per amino acid in the polypeptide backbone except proline) The position of these peaks in the spectrum is very sensitive to the structural environment of the resonating 15 N, 13 C-labeled RGD-hirudin was same capable of inhibiting platelet aggregation induced by ADP; two samples 0.14 mmol/l could inhibit the platelet aggregation, and their inhibitory effect on the platelet aggregation were dose-response. doi:10.1371/journal.pone.0042207.g002
NMR
Analysis of 15 N, 13 C-Labeled the RGD-Hirudin obtained, which can help to resolve a number of uncertainties in assignments due to degeneracy or the close similarity of backbone chemical shifts [24] . Almost complete 15 N, 13 C and 1 H resonance assignments of the backbone in r-RGD-Hirudin are reported (Table 3) .
Discussion
Two cultures were used under the same conditions, except for the nitrogen source and carbon source. In the first culture, NH 4 OH was used as the nitrogen source and for controlling the pH; unlabeled glycerol and methanol were used as the carbon source. In the second culture, ( 15 NH 4 ) 2 SO 4 , 13 C-labeled glycerol, Figure 3 . Purity and molecular weight of 15 N, 13 C-labeled RGD-hirudin were determined by HPLC-MS. a. HPLC analysis of purified 15 N, 13 C-labeled RGD-hirudin showed the purity was up to 98%. b. Mass spectrometry of the purified proteins for unlabeled RGD-hirudin showed its molecular weight was 7021 Da c. The molecular weight of 15 N, 13 C-labeled RGD-hirudin was 7387 Da The total labeling ratio is more than 98%. doi:10.1371/journal.pone.0042207.g003 Analysis of 15 and 13 C-labeled methanol were used and a mixture of 4 mol/L KOH and 7.4 mol/L NaOH was used for pH control, as described in the Materials and Methods. (NH 4 ) 2 SO 4 is known to inhibit cell growth, because it generates K 2 SO 4 and increases the ionic strength of the culture medium [12] , so ( 15 NH 4 ) 2 SO 4 was added sequentially and the total amount was optimized, as described in the Materials and Methods. Both unlabeled (data not shown) and labeled RGD-hirudin were then expressed with about 20 h of methanol induction and were analyzed by SDS-PAGE. The final expression level was approximately 0.75 mg/mL.
The goal of this study was to obtain abundant 15 N, 13 C-labeled RGD-hirudin. Our results showed that high-density fermentation was well-suited for the production of 15 N, 13 C-labeled RGDhirudin. During fermentation, KOH and NaOH were used to control pH, instead of NH 4 OH. ( 15 NH 4 ) 2 SO 4 was used as the sole nitrogen source. Wood et al. reported that as the salt concentration was increased, a medium exchange was recommended for a Mut S strain [25] . In our experiment, no medium exchange was carried out, and we suggest that salt concentration may not affect a Mut + strain. After a three-step purification, we obtained sufficient 15 N, 13 C-labeled RGD-hirudin for a NMR study. In NMR experiments, the spectra were affected by the concentration, pH, temperature, and salts. Previously, 1 H NMR spectra of unlabeled RGD-hirudin were obtained at pH 7.4, and a concentration of 5 mmol/L [11] . For the 15 N-1 H HSQC spectrum, the signals were largely improved. When the sample concentration was 5 mmol/L, some cross peaks overlapped in the spectrum. The HSQC spectra of RGD-hirudin at different concentrations (2.0, 1.0, and 0.6 mmol/L) showed that even at 0.6 mmol/L, the peaks could be clearly separated. However, at 0.6 mmol/L, most peaks disappeared after injecting thrombin into RGD-hirudin in the initial NMR titration experiments (data not 
Conclusions
In a previous study, we confirmed the function of RGD-hirudin, inhibiting thrombin and platelet aggregation, which may indicate RGD-hirudin will be useful in clinical applications [8] . RGDhirudin needed to be modified, based on structure-function relationships, for advanced clinical use. Our lab has previously conducted a study on the solution structure of RGD-hirudin (1-49) [9] . Although 15 N-labeled RGD-hirudin from Pichia pastoris was obtained, the structure of the C-terminal domain (from Ser 50 to Glu 66 ) has not yet been worked out. To study the relationship between the molecular structure in solution and ligand-binding properties, we have now prepared 15 N/ 13 C double-labeled RGDhirudin in sufficient quantities to permit a full determination of the structure and dynamics of RGD-hirudin (1-66) using heteronuclear NMR spectroscopy. Almost complete backbone 1 H 15 N, 13 C and 13 CO assignments of RGD-Hirudin have been obtained. Complete side-chain assignment is in progress by using the combination of HCCH-COSY and HCCH-TOCSY now.
